Hims and Hers Is Scaling Rapidly, But Management Needs To Address The Difficult Questions
At first glance, Hims & Hers Health, Inc. (NYSE:HIMS) delivered the kind of result that investors typically reward.
Hims & Hers Health Inc. (HIMS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 6,067,800 | $210,370,626 | -13% | 0.02% | |
| 2. | Divisadero Street Capital William Zolezzi | 6,009,505 | $208,349,538 | +1180% | 4.72% |
| 3. | 4,319,800 | $149,767,466 | +463% | 0.07% | |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 4,217,767 | $146,229,983 | +483% | 0.12% |
| 5. | 3,124,600 | $108,329,882 | -26% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.24 | 48,400 | $1,172,974.00 | 224,417 | 2026-05-26 | Filing | |
| $24.50 | 1,000 | $24,500.00 | 5,000 | 2024-11-14 | Filing | |
| $26.94 | 4,000 | $107,759.60 | 4,000 | 2024-11-12 | Filing | |
| $17.74 | 110,000 | $1,951,763.00 | 110,000 | 2024-05-21 | Filing | |
| $3.66 | 73,700 | $269,742.00 | 125,000 | 2022-06-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.95 | 29,277 | $876,846.15 | 236,527 | 2026-09-22 | Filing | |
| $28.82 | 12,313 | $354,860.66 | 251,804 | 2026-09-17 | Filing | |
| $27.86 | 6,236 | $173,734.96 | 304,270 | 2026-09-16 | Filing | |
| $28.39 | 14,027 | $398,226.53 | 456,660 | 2026-09-15 | Filing | |
| $28.39 | 7,954 | $225,814.06 | 185,556 | 2026-09-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 28,703,514 | $995,150,830 | 0.01% | |
| 2. | 13,539,700 | $469,421,399 | 0.04% | |
| 3. | 10,559,314 | $366,091,416 | 0.02% | |
| 4. | 9,541,384 | $330,799,783 | 0.01% | |
| 5. | 9,004,900 | $312,199,883 | 0.02% |
News See All
J.P. Morgan Assigns Hims & Hers Stock a ‘Hold’ Rating. What’s Behind the Cautious Stance?
J.P. Morgan analyst Bryan Smilek initiated coverage of telehealth platform Hims & Hers Health ($HIMS) with a Hold rating and a price target of $32....
Hims & Hers Health Bolsters International Footprint with Australian Launch
Telehealth platform Hims & Hers Health ($HIMS) is strengthening its international presence by expanding into Australia. This marks the company’s fo...
Hims & Hers’ Australia Expansion Adds Growth, But Execution Will Be Key
Hims & Hers Health, Inc. (NYSE:HIMS) has entered Australia, marking its first expansion into the Asia-Pacific market.
Hims & Hers (HIMS)' Weight-Loss Plans Results Penalties Over Visa (V) Credit Card Disputes
On August 21, 2026, Bloomberg reported that Hims & Hers Health, Inc. (NYSE:HIMS) was enrolled in Visa Inc.
Hims & Hers (HIMS) CEO Says the FTC Doesn't Understand His Own Company
On August 18, 2026, Hims & Hers Health, Inc.
Hims & Hers Health Hit With Visa Penalties as Weight-Loss Complaints Surge
Telehealth company Hims & Hers Health ($HIMS) is facing penalties from payments giant Visa ($V) after customer credit card disputes in its weight-l...
Hims & Hers (HIMS) Raised Guidance. Can Growth Survive Its GLP-1 Margin Reset?
Hims & Hers Health, Inc. (NYSE:HIMS) shares fell over 6% in extended trading on August 10 after the telehealth company delivered another quarter of rapid growth alongside sharply weaker profitability.
Hims & Hers Stock (HIMS) Slides as GLP-1 Push Swallows Profits and Widens Q2 Loss
Shares of Hims & Hers Health ($HIMS), a U.S. telehealth firm, fell over 7% in premarket trading on Tuesday after reporting a more-than-expected Q2 ...
Hedge Fund Resource Center